Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity

Driven by the ever-increasing pace of drug discovery and the need to push the boundaries of unexplored chemical space, medicinal chemists are routinely turning to unusual strained bio­isosteres such as bicyclo[1.1.1]­pentane, azetidine, and cyclobutane to modify their lead compounds. Too often, howe...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 139; no. 8; pp. 3209 - 3226
Main Authors Lopchuk, Justin M, Fjelbye, Kasper, Kawamata, Yu, Malins, Lara R, Pan, Chung-Mao, Gianatassio, Ryan, Wang, Jie, Prieto, Liher, Bradow, James, Brandt, Thomas A, Collins, Michael R, Elleraas, Jeff, Ewanicki, Jason, Farrell, William, Fadeyi, Olugbeminiyi O, Gallego, Gary M, Mousseau, James J, Oliver, Robert, Sach, Neal W, Smith, Jason K, Spangler, Jillian E, Zhu, Huichin, Zhu, Jinjiang, Baran, Phil S
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.03.2017
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Driven by the ever-increasing pace of drug discovery and the need to push the boundaries of unexplored chemical space, medicinal chemists are routinely turning to unusual strained bio­isosteres such as bicyclo[1.1.1]­pentane, azetidine, and cyclobutane to modify their lead compounds. Too often, however, the difficulty of installing these fragments surpasses the challenges posed even by the construction of the parent drug scaffold. This full account describes the development and application of a general strategy where spring-loaded, strained C–C and C–N bonds react with amines to allow for the “any-stage” installation of small, strained ring systems. In addition to the functionalization of small building blocks and late-stage intermediates, the methodology has been applied to bio­conjugation and peptide labeling. For the first time, the stereospecific strain-release “cyclopentyl­ation” of amines, alcohols, thiols, carboxylic acids, and other heteroatoms is introduced. This report describes the development, synthesis, scope of reaction, bio­conjugation, and synthetic comparisons of four new chiral “cyclopentyl­ation” reagents.
Bibliography:NIH RePORTER
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-7863
1520-5126
DOI:10.1021/jacs.6b13229